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ABSTRACT The role of b-sheets in the early stages of protein aggregation, speciﬁcally amyloid formation, remains unclear.
Interpretations of kinetic data have led to a speciﬁc model for the role of b-sheets in polyglutamine aggregation. According to
this model, monomeric polyglutamine, which is intrinsically disordered, goes through a rare conversion into an ordered, meta-
stable, b-sheeted state that nucleates aggregation. It has also been proposed that the probability of forming the critical nucleus,
a speciﬁc b-sheet conformation for the monomer, increases with increasing chain length. Here, we test this model using molec-
ular simulations. We quantiﬁed free energy proﬁles in terms of b-content for monomeric polyglutamine as a function of chain
length. In accord with estimates from experimental data, the free energy penalties for forming b-rich states are in the
10–20 kcal/mol range. However, the length dependence of these free energy penalties does not mirror interpretations of kinetic
data. In addition, although homodimerization of disordered molecules is spontaneous, the imposition of conformational restraints
on polyglutamine molecules does not enhance the spontaneity of intermolecular associations. Our data lead to the proposal
that b-sheet formation is an attribute of peptide-rich phases such as high molecular weight aggregates rather than monomers
or oligomers.INTRODUCTION
Nine neurodegenerative diseases are associated with poly-
glutamine expansion mutations (1). Ages of onset and
severity of disease at onset are inversely correlated with the
lengths of polyglutamine expansions (2). Proteolysis of
mutant proteins releases fragments rich in polyglutamine
that aggregate to form insoluble neuronal intranuclear inclu-
sions (3). Aggregates are fibrillar and amyloidlike (4) with
high b-sheet contents. Based on fiber diffraction data, Perutz
et al. proposed amodel in which the individual polyglutamine
molecules within aggregates are arranged in a b-helical
conformation (5). The fiber diffraction data have also been
shown to be consistent with flat b-sheet architectures for indi-
vidual polyglutamine peptides (6).
In contrast to structures adopted by individual polyglut-
amine molecules in fibrillar aggregates, monomeric poly-
glutamine molecules have spectroscopic signals that indicate
a lack of well-defined secondary structures (7,8). It has also
been shown that monomeric polyglutamine forms collapsed
structures in water (9), and this observation is consistent with
water being a poor solvent for polyglutamine (10). Mono-
meric polyglutamine is intrinsically disordered, irrespective
of chain length, and these molecules sample heterogeneous
ensembles of collapsed structures in water.
Chen et al. (11) proposed a model to connect intrinsically
disordered monomers and b-sheet structures that are promi-
nent in fibrillar forms. Analysis of kinetic data using a homo-
geneous nucleation model yielded a nucleus size of one (11).
The results were interpreted as follows: Monomeric poly-
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0006-3495/09/07/0303/9 $2.00glutamine is in a preequilibrium between a folded, toxic,
b-sheet structure and the disordered ensemble. Whenever
the toxic fold is adopted, the thermodynamically unfavorable
nucleus is populated and the resulting ordered conformation
is elongated through monomer addition. A schematic of this
proposal is shown in Fig. 1. The proposal put forth by Chen
et al. is difficult to test experimentally because the critical
nucleus is, by definition, a rare species.
Recently (12), we corroborated experimental results that
polyglutamine chains spanning the pathological threshold
range for Huntington’s disease (N z 37) adopt disordered,
compact conformations at the monomer level. We also
showed that they associate spontaneously to form disordered
dimers. These studies were carried out using the ABSINTH
implicit solvation model combined with the all atom OPLS-
AA/L force field (12,13). Here we use the same combination
of force field and implicit solvation model to answer a set of
questions and test all aspects of the homogeneous nucleation
model proposed by the analysis of Chen et al. (11) and Bhat-
tacharya et al. (14). The questions of interest are as follows:
What is the probability that monomeric polyglutamine
forms structures with high b-content under ambient
conditions?
Are such species metastable states along a reaction coor-
dinate that measures the net b-content of the chain?
How does the likelihood of forming species high in
b-content vary with chain length?
If we bias individual polyglutamine chains toward struc-
tures with high b-content, do we observe a change in
the spontaneity of dimer formation?
Finally, do our results support the idea of a structure-
driven, homogeneous nucleation pathway for poly-
glutamine aggregation?
doi: 10.1016/j.bpj.2009.05.003
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duce the details of our methodology. This is followed by
a presentation of results that allow us to answer the questions
raised above and we conclude with a summary and discus-
sion of our results.
MATERIALS AND METHODS
Degrees of freedom and force ﬁeld
We simulated one- or two-polyglutamine molecule n-acetyl-(Gln)N-n
0-meth-
ylamide; the chains were modeled in atomic detail and the number of gluta-
mine residues was set to N ¼ 5, 15, 30, and 45, respectively. Chains with N
glutamine residues are denoted as QN. Markov chain Metropolis Monte
Carlo (MC) Simulations were performed in the canonical ensemble and
molecules were enclosed in a spherical droplet of radius 200 A˚, which
was enforced using a stiff harmonic boundary potential. The degrees of
freedom were the backbone f, j, u, and side-chain c-dihedral angles. For
MC simulations with two chains, rigid-body coordinates, namely center-
of-mass translations and rotations, were included as additional degrees of
freedom. Bond lengths and bond angles were held fixed at values prescribed
by Engh and Huber (15).
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FIGURE 1 Schematic of possible aggregation pathways for polyglut-
amine in vitro; n denotes the number of polyglutamine molecules within
a disordered aggregate and nF denotes the number of polyglutamine mole-
cules within an ordered amyloid fibril. The ordered amyloid fibril rich in
b-sheets is shown in the bottom-right corner of the schematic. The gray-
shaded region encompasses steps a, e, c, and d and depicts the homogeneous
nucleation proposal of Chen et al. (11). We investigated the thermodynamics
of step a, which indicates that the formation of ordered conformations is
thermodynamically unfavorable. Monomeric polyglutamine prefers disor-
dered, collapsed conformations, to the left of step a. Step b pertains to the
thermodynamics of interactions between chains that have been restrained
to adopt ordered conformations. Associativities of restrained chains—step
b—are akin to the associativities of unrestrained chains—step g. However,
the likelihood that chains will sample the associations shown in step b is very
small, because this is tied to the equilibria in step a, which requires the pop-
ulation of the conformations with high b-content. Fig. 3 shows that this is
highly unlikely. Similarly, step f shows that disordered dimers are thermody-
namically favored to dimers with high b-contents in individual chains. This
is the result of linkage to step a as discussed above. The aggregates achieved
in step h are likely to be large (in terms of n) and exhibit spherical, ‘‘liquid-
like’’ (31,32,34) organization of polyglutamine chains around each other.
Step i depicts a slow conformational conversion of individual/small numbers
of chains to b-sheets. This slow step is likely to lead to the creation of an
ordered template for fibril formation via monomer or oligomer addition
and elongation to yield the ordered amyloid fibril. Steps a, b, and g are
anchored in the collection of data generated in this work and previous
studies. However, the reversible associations depicted in step h and the
conformational conversions depicted in step i are yet to be tested.Biophysical Journal 97(1) 303–311We used parameters from the OPLS-AA/L force field (16) with appro-
priate modifications and the ABSINTH implicit solvent model (13). The
energy function is
Etotal ¼ Wsolv þ Wel þ ULJ þ Utor: (1)
Here,Wsolv is the direct mean-field interaction term that captures the transfer
of a polypeptide solute in a specific conformation from the gas phase into the
continuum solvent.Wel denotes the mean-field electrostatic term; the dielec-
tric constant of the solvent is set to be 3 ¼ 78. ULJ models van der Waals
interactions using the Lennard-Jones (LJ) model. Parameters for the LJ
hard-sphere radii and well depths are based on heats of fusion data for model
compounds and are different from the choices made in standard force fields.
This choice allows us to omit many of the torsional potentials because the
rotational barriers and minima are captured by excluded volume interactions
alone (13). Utor represents torsional terms applied to dihedral angles that
cannot be captured by ULJ. For polyglutamine, we use torsional potentials
taken from OPLS-AA/L to maintain peptide dihedral angles (u) in predom-
inantly trans-configurations.
Salient features of the interplay between the Wsolv and Wel terms are
summarized as follows: Polypeptide chains are decomposed into a set of
distinct solvation groups; for capped polyglutamine, the solvation groups
are Nþ1 backbone secondary amides and N side-chain primary amides.
Wsolv is a sum of contributions from each solvation group and for each of
these groups we use experimentally measured free energies of solvation of
appropriate model compound analogs as references for fully solvated states.
The degree of solvent accessibility modulates the direct mean-field interac-
tion and consequently Wsolv varies with conformation. Solvent-accessible
volume fractions are used as the metric for solvent accessibility and this is
used to evaluate the solvation states yik for atom k in solvation group i. Elec-
trostatic interactions between nonbonded solute atoms with partial charges
are fully screened by the continuum dielectric if the atoms are fully exposed
to solvent. The screening of polar interactions is conformation-dependent
and the solvation states of atoms yik determine the extent to which the
screening of electrostatic interactions is modulated. ABSINTH is built
upon the distinct strengths of the generalized Born (GB) (17–19) and
EEF1 (20) models. In accord with EEF1, the process of transferring solutes
from the gas phase into the continuum solvent is treated in ‘‘one shot’’
without attempting to parse the distinct contributions from the polar and
nonpolar components. However, ABSINTH deviates from EEF1 in the
way electrostatic interactions between solute atoms are handled. No explicit
or implicit distance-dependence is assumed for the dielectric response.
Instead, solvation states of individual atoms yik are used to determine the
extent to which the screening of electrostatic interactions is to be modulated
by the protein environment. ABSINTH therefore captures the main strengths
of the GB model while retaining the efficiency of the EEF1 model and it may
be viewed as an effective interpolation between GB and EEF1.
Sampling methodology
Move sets for MC simulations included pivots about random backbone
torsions, perturbations about random dihedrals, randomized side-chain rota-
tions, and randomized changes to rigid body coordinates. Details regarding
the move sets are summarized in Table S1 in Supporting Material. One of
our goals was to quantify free energy penalties associated with sampling
of b-rich conformations for monomeric polyglutamine. We defined a reac-
tion coordinate fb to assess global b-content within a molecule and used
umbrella sampling to enhance the sampling of the low-likelihood regions
of conformational space. Results of independent umbrella sampling calcula-
tions were stitched together using weighted histogram analysis methods
(WHAM) (21,22) to generate unbiased potentials of mean force (PMFs)
as a function of fb, which is defined as
fb ¼ 1
N
XN
i¼ 1
f
ðiÞ
b ;
where
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(3)
Here, N is the number of glutamine residues in the sequence, mod2p terms
correct for periodicity effects associated with distance calculations in angular
space; (fb,jb) define the reference (f,j) values for an individual residue. If
residue i adopts f- and j-angles that lie within a circle of radius rb, then
the parameter fb
(i) is set to unity; otherwise, fb
(i) has a value between 0 and
1; the precise value is determined by two parameters, namely d(i)
2 and tb.
The latter is thewidth of theGaussian function and ensures a continuous func-
tion. We used: (fb,jb) ¼ (152, 142), rb ¼ 50, and tb ¼ 0.002 deg2.
We assessed the validity of fb as a measure of b-content by quantifying its
ability to estimate b-content in proteins of known three-dimensional struc-
tures. We used PDBSelect (23) to create a database of 3693 nonredundant
protein structures from the Protein Data Bank. Sequences in this dataset
have<25% sequence identity with each other. For each structure in the data-
set, we calculated the fb values and their DSSP-E score (24), normalized by
the number of residues, as an alternative to measure the degree of ordered
b-sheet. Fig. 2 shows the correlation between fb and fractional DSSP-E scores.
The correlation coefficient is 0.83. Fig. S1 shows ribbon drawings of three-
dimensional structures for five structures from the database. Since we do not
have definitive prior knowledge of the type of ordered b-sheets that poly-
glutamine molecules adopt in fibrillar aggregates, we used fb instead of frac-
tional DSSP-E scores as a reaction coordinate for assessing the bias toward
structures with high or low b-contents.
Simulations for monomeric polyglutamine were carried out at 298 K. For
each chain length, we performed 17 sets of distinct umbrella sampling
simulations and in each simulation, fb was restrained to one of 17 target fb
0
FIGURE 2 Correlation between fractionalDSSP-E scores and fb: The solid
line is the line of best fit that quantifies the strength and direction of the linear
correlation between fb values and fractional DSSP-E scores. Parameters for
the slope and intercept are shown in the inset. Structures that have high frac-
tional DSSP-E scores also have high fb values, although there is some scatter
about the line of best fit. For ~27% of the structures in the dataset, the frac-
tional DSSP-E scores are zero. Although the fb values for most of these struc-
tures are small (%0.3), they span a finite range of fb values.values: [0.0, 0.1, 0.2, 0.25, 0.3, 0.35, 0.4, 0.45, 0.5, 0.55, 0.6, 0.7, 0.75,
0.8, 0.9, 0.95, 1.0]. Each simulationwas biased toward a target value fb
0 using
a harmonic restraint potentialUrestr¼ k(fb fb0)2 that was added to the energy
function shown in Eq. 1. The number of (f,j) pairs that contribute to fb
increases with N and the value of k varied with N. We used values of k ¼
25 kcal/mol and 75 kcal/mol for Q5 and Q15, and k ¼ 150 kcal/mol for Q30
and Q45, respectively. Therefore, k varies from 1.7 kcal/mol (Q45) to
2.5 kcal/mol (Q5, Q15, and Q30) per restrained degree of freedom.
For each window, the starting conformation was extracted at random from
an ensemble of self-avoiding random walks. For Q5, Q15, and Q30 the first
106 MC steps were used for equilibration followed by 4  107 steps of
production. For Q45, we used 1.5  106 steps of equilibration and 6  107
steps of production. Sampling was enhanced using replica exchange MC in
fb-space (25). For each chain length, we performed three independent replica
exchange umbrella samplingMC runs. The quality of sampling was assessed
by computing statistics for the extent of overlap of fb histograms between
adjacent windows and statistics for replica exchange. These details are docu-
mented in Fig. S3, Fig. S4, and Fig. S5.
The WHAM protocol has two components, namely iterative computation
of relative free energies between adjacent windows and the construction of
unbiased PMFs. Data from restrained simulations were analyzed using
WHAM in three different ways. In the first two methods, both components
of the WHAM protocol are used, with the only difference being the method
used to compute error bars for the unbiased PMFs. The first method reports
error bars as standard errors and the second method uses a bootstrap proce-
dure to estimate error bars. For the third method, the relative free energies
between adjacent windows were computed using thermodynamic integration
(TI) and the unbiased PMF was computed using WHAM. All the details
regarding error analysis and TI-WHAM are provided in the Supporting
Material.
For polyglutamine dimer simulations, we combined MC simulations with
thermal replica exchange. In two of the three sets of simulations, each chain
was restrained to target fb
0 values of ¼ 0.75 and 1.0, respectively, whereas
the third simulation set involved unrestrained molecules. For each chain
length, we carried out three independent replica exchange runs. The
following Kelvin temperature schedule was used for the replica exchange
simulations: [298, 305, 315, 325, 335, 345, 355, 360, 370, 380, 390]. The
temperature schedule was based on data for coil-to-globule transitions of
unrestrained monomeric polyglutamine. As shown in Fig. S2, temperature
modulates the solvent quality. Temperatures in the range T% 355 K corre-
spond to the poor solvent regime, where monomeric polyglutamine prefers
globules; temperatures in the range 355 K < T < 420 K are in the transition
region between globule and coil, and higher temperatures correspond to
swollen coils. The q-point (Tq) was found to be ~390 K (see caption to
Fig. S2). We wish to quantify the spontaneity of intermolecular associations
in the poor solvent regime. The overlap between coil and globule ensembles
is small and decreases with increasing N. Therefore, we set the upper limit
for the replica exchange temperature schedule to be Tq, to ensure that the
replicas were used judiciously. We quantified overlap statistics and accep-
tance ratios for swaps between adjacent thermal replicas to demonstrate
the adequacy of the protocol, and details are in Fig. S6, Fig. S7, and Fig. S8.
RESULTS
Conformations with high b-content are
thermodynamically unfavorable for monomeric
polyglutamine
Fig. 3 A shows free energy profiles for monomeric polyglut-
amine of four chain lengths. Fig. 3, B and C, shows the same
free energy profiles, except that the profile in Fig. 3 B shows
the bootstrap errors, whereas Fig. 3 C shows the free energy
profiles constructed using the TI-WHAM procedure. The
free energy profiles along fb are smooth and possess broadBiophysical Journal 97(1) 303–311
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because the peptide is short and cannot collapse on itself.
For longer chains, the minima are located at values of
fbz 0.3, which is the value preferred by unrestrained poly-
glutamine chains. The Q15 chain possesses a tendency for
forming a-helical segments (12). This helix propensity is
the reason for the flatness of the free energy profile for values
of fb <0.3 for this peptide. Decreased a-helical propensities
for longer chain lengths lead to an increase in the free energy
penalty for fb < 0.3.
The free energy profiles do not show evidence for distinct
local minima. This is confirmed by analyzing the derivatives
of each of the PMFs. In the harmonic limit with a single
minimum, a mean force profile will be a straight line and
this is what we observe as shown in Fig. 3 D. Therefore,
monomeric polyglutamine does not access metastable
conformations with high fb values. Bhattacharya et al. (14)
estimated the nucleation free energy for Q47 to be roughly
12 kcal/mol. Beta-rich structures will have fb values between
0.6 and 0.7 (Fig. 2 and Fig. S1). Free energy penalties asso-
ciated with accessing such structures are in the range of
10–15 kcal/mol for Q45 (Fig. 3 A). This is in the range of
the estimate obtained by Bhattacharya et al.
Bhattacharya et al. also proposed that aggregation rates
increase with increasing chain length because free energy
penalties associated with forming b-rich structures decrease
with increasing chain length (11,14). The calculated free
energy profiles do not support this hypothesis. The free energy
penalty for forming structures with high fb values increases
with increasing chain length. However, this increase in free
energy penalty levels off for Q45 because the PMFs for Q30
and Q45 resemble each other—more so than those for Q30
and Q15. We previously showed that the stability of nonspe-
cifically collapsed states increases with increasing chainBiophysical Journal 97(1) 303–311length (12). Here, we show that the likelihood of populating
structures with high fb values decreases with increasing chain
length. The former observation is consistent with the physics
of flexible polymers in a poor solvent, whereas the latter
observation is congruent with the idea that energetic frustra-
tion (26) makes it difficult for flexible, homopolymeric poly-
glutamine to adopt well-ordered three-dimensional structures
in their monomeric forms.
Restraining monomeric polyglutamine to high fb
values provides access to ordered b-sheet
conformations
Fractional DSSP-E scores (24) based on analysis of
hydrogen-bonding patterns are a complementary measure
of secondary structure. Fig. 4 plots data for monomeric poly-
glutamine with fractional DSSP-E scores along the ordinate
and fb values along the abscissa. Data were extracted from
the simulations that were performed in the presence of
restraints on fb. We do not observe any structures for which
the fb value is low when the fractional DSSP-E score is
high. Structures with characteristic b-sheet hydrogen-bond
patterns have high fractional DSSP-E scores as well as high
fb scores. However, for moderate to high fb values, there is
a substantial spread in the observed fractional DSSP-E
scores, implying that polyglutamine samples disordered
conformations lacking regular backbone-backbone hydrogen
bonds even when fb is restrained to a high value.
Persistence of disorder in the presence of
restraints results from a diverse registry
of intramolecular hydrogen bonds
We asked whether disordered structures contain large
numbers of hydrogen bonds, which are either unsatisfied orA
C D
B
FIGURE 3 Potentials of mean force (PMFs) for mono-
meric polyglutamine chains of different lengths. The
profiles are plotted as a function of fb, which is a reaction
coordinate that measures b-content. (A) PMFs with stan-
dard errors, (B) with bootstrap errors, and (C) PMFs that
result from using TI-WHAM with a coarse fb schedule.
Details are described in the Supporting Material. (D) Lines
of best fit to the data for the derivatives of the PMFs shown
in panel A. The insets show the Pearson correlation coeffi-
cients—r2—that diagnose the strength and direction of the
hypothesis that the PMF derivatives (forces) are linear. The
slopes and intercepts for the lines of best fit are as follows:
Q5 (0.25, 0.05), Q15 (2.00, 0.27), Q30 (5.74, 1.38),
and Q45 (9.5, 2.65). Slopes have units of kcal/mol-fb
and intercepts have units of kcal/mol.
b-Content in Polyglutamine 307assumed to be satisfied by the solvent. In Fig. 5, we plot the
average number of intramolecular hydrogen bonds per back-
bone and side-chain oxygen (acceptor) atom in monomeric
polyglutamine as a function of chain length. All four types
of hydrogen bonds including backbone acceptor to backbone
donor, side-chain acceptor to side-chain donor, backbone
acceptor to side-chain donor, and side-chain acceptor to back-
bone donor, make roughly equivalent contributions to the
total hydrogen-bond inventory. No obvious preference for
specific intramolecular contacts is seen, even in the presence
of restraints. Summing up around the acceptor sites, the
average number of hydrogen bonds per backbone side-chain
acceptor is less than unity, indicating that a substantial frac-
FIGURE 4 Scatter plot of all recorded snapshots in all simulations for
Q15, Q30, and Q45 correlating the fractional b-content according to DSSP
with the values for fb at 298 K. Dots of different colors correspond to chains
of different length. Representative points are marked using stars and the cor-
responding structures are shown in cartoon representation. Graphics were
generated using VMD (35). Note that the fractional b-content according to
DSSP is an inherently discrete quantity for chains of finite length. Q5 is
not shown since the chain is too short to have nonzero DSSP-E scores.tion of hydrogen bonds is satisfied by the solvent. The average
number of intramolecular hydrogen bonds per acceptor is
generally larger for the unrestrained case. Restraints to high
values of fb increase the number of solvent-exposed acceptors
leading to increased interfaces with the surrounding solvent.
Despite the restraints, the peptides prefer the full spectrum
of intramolecular and chain-solvent contacts.
Dimerization of polyglutamine remains
spontaneous in the presence of restraints
We asked whether the spontaneity of homodimerization is
altered when each chain is restrained to adopt high values of
fb. We simulated dimerization of polyglutamine for chains of
length N ¼ 5, 15, 30, and 45 as a function of temperature and
two different values for the target restraint, fb
0. If the homoge-
neous nucleationmodel applies for polyglutamine aggregation,
then associations involving restrained chains should be
stronger than the associations involving unrestrained chains.
To quantify associativity, we computed a temperature-depen-
dent excess interaction coefficient, B22(T), which we intro-
duced in previous work and recapitulate below:
B22ðTÞ ¼
RR¼ ddroplet
R¼ 0
½FT¼TqðRÞ  FTðRÞR2dR
RR¼ ddroplet
R¼ 0
FT¼TqðRÞR2dR
: (4)
Here, FT(R) is the cumulative distribution function for the
intermolecular distance at temperature T; ddroplet ¼ 400 A˚ is
the diameter of the simulation system. When spontaneous
associations are favored compared to Tq, B22(T) is negative.
If chains interact the way theywould at Tq, thenB22(T) is zero.
Fig. 6 plots B22(T) as a function of T for different chain
lengths in the presence and absence of restraints on fb. The
associativity of chains is length- and temperature-dependent,
but it does not vary with the presence or absence ofA B
C D
FIGURE 5 Average number of hydrogen bonds per
acceptor oxygen atoms. Data are shown for hydrogen
bonds around the backbone (A and C) and side-chain
(B andD) acceptor oxygen atoms, respectively. BB denotes
backbone and SC denotes side chains. Values are shown
for T ¼ 298 K and three different chain lengths (Q15,
Q30, Q45) and restraint values. Hydrogen bonds were deter-
mined using the general definition introduced by Kabsch
and Sander (24).Biophysical Journal 97(1) 303–311
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FIGURE 6 Plots of B22(T) as a function of temperature.
Each panel shows B22(T) extracted from simulations with
unrestrained chains and simulations where each chain in
the simulation has a target restraint of fb
0 ¼ 0.75 or
fb
0 ¼ 1.0.conformational restraints. Fig. 6 A shows that the short Q5
peptide remains nonassociative across the entire simulated
temperature range. For Q15, the differences in associativity
with and without restraints are statistically insignificant. At
the lowest temperatures, B22 is negative for restrained as
well as unrestrained chains. It increases monotonically
with increasing temperature and reaches zero between 320
and 340 K. This temperature range represents the stability
limit for the associated dimer. Fig. 6, B and C, show the
same data for Q30 and for Q45. As chain lengths increase,
the stability limit for associated dimers shifts to higher
temperatures. Within the statistical accuracy of the data,
chains with restraints are as associative (not more associa-
tive) as unrestrained chains.
For high values of fb, the surface/volume ratio increases
with respect to the unrestrained chains (see Fig. S9). This
does not translate into increased associativity with respect
to the unrestrained chains. Instead, the actual poorness of
the solvent (the value of T) remains the main determinant
of the spontaneity of intermolecular associations. This obser-
vation is confounding since solute-solvent interfaces
increase for monomeric polyglutamine when restraints
toward high fb are imposed. We quantified the solvent-solute
interface for monomeric polyglutamine by asking if interfa-
cial energies were insensitive to the presence or absence of
conformational restraints. We decomposed the system ener-
gies (excluding the restraint potential) into bulk (volumetric)
and surface contributions (27) by fitting the system energies
to the functional form shown in Eq. 5. Here, C1 and C2
measure the effective strengths of volumetric self-interac-
tions and surface terms, respectively,
hUtotal  Urestri
N
¼ C1

T; f 0b

þ C2

T; f 0b

,N1=3; (5)
where N is the chain length, Utotal is the system energy, and
Urestr is the restraint potential energy. Fig. 7 plots C1 and C2Biophysical Journal 97(1) 303–311as a function of temperature for different values of fb
0. When
compared to the unrestrained simulations, the C1 term in the
collapse regime is less favorable in the presence of restraints
indicating the high free energy of structures with high values
of fb. Additionally, for a given temperature, values for C2 are
more positive because larger interfaces with the surrounding
solvent are more unfavorable than the smaller solute-solvent
interfaces made by unrestrained chains. As T/Tq, C2
approaches zero indicating that the interface is indifferent
with respect to interactions with either solvent or the chain.
This is Flory’s definition of the q-state. For temperatures
>Tq z 390 K, C1 converges to a value of ~–20 kcal/mol.
This is the approximate mean-field energy for a fully
A B
FIGURE 7 Energy density C1 (A) and surface energy term C2 (B) for
monomeric polyglutamine. Data were obtained for unrestrained polyglut-
amine and two other simulations with restraints on fb. The quality of the
fits underlying these data cannot be accurately assessed since they are fits
to data from only three chain lengths (because we exclude Q5 excluded
from analysis, since it is too short for a volumetric term to contribute).
b-Content in Polyglutamine 309solvated glutamine residue within the ABSINTH Hamilto-
nian (13), and is the expected limiting value for a chain
preferring chain-solvent interactions to chain-chain interac-
tions. Therefore, in the presence of restraints toward high
target values of fb, the chains swell and form energetically
unfavorable interfaces with the surrounding solvent.
However, these features do not translate into differences in
B22 compared to the unrestrained chains.
Restraints toward high values of fb promote the
formation of canonical b-sheets
Fig. 8 shows the average fractional DSSP-E scores observed
in monomer and dimer simulations with fb
0¼1 compared to
the data obtained from simulations with unrestrained chains.
When the free energy penalty for sampling high fb values is
prepaid, the resultant increase in solute-solvent interface at
FIGURE 8 Bar plots comparing the average fractional DSSP-E scores in
simulations of monomeric polyglutamine to simulations of dimeric polyglut-
amine at 298 K. Data are shown for three chain lengths using data from
simulations with unrestrained chains as well as data from simulations for
fb
0 ¼ 1.0.the monomer level results in increased b-sheet formation
through a coupling between inter- and intramolecular inter-
actions. This difference is suggestive of intermolecular inter-
faces being responsible for promoting b-sheet content. To
provide a visual perspective of increased b-sheet content in
dimers formed with restrained chains, Fig. S10 shows
a scatter plot in the space of the two parameters, fb and
fractional DSSP-E scores. Fig. 9 shows a bar plot of intermo-
lecular hydrogen bonds to quantify the interactions in
intermolecular interfaces. Intermolecular hydrogen bonds
predominantly involve glutamine side chains. There is
a significant enhancement in intermolecular backbone-back-
bone hydrogen bonds for Q15 and Q30 when fb
0 ¼ 1.0 and is
congruent with data in Fig. 8. Interestingly, the per-molecule
PMF obtained via WHAM for two Q30 molecules in the
simulation system is virtually identical to the one obtained
for the monomer (data not shown). Hence, we conjecture
that larger oligomers must form to facilitate spontaneous
conversion of individual chains to b-rich conformations.
DISCUSSION
Monomeric polyglutamine encompassing the threshold
length for Huntington’s disease does not adopt conforma-
tions rich in b-content. Such conformations have been
proposed as putative nuclei for polyglutamine aggregation
(11). Our estimate of the free energy penalty associated
with forming structures with high b-content is in the range
of estimates proposed in the literature (14). However, these
penalties increase with increasing chain length and may
plateau past a certain chain length. Our observations contra-
dict the expectations of Bhattacharya et al. (14), who
proposed that the free energy penalties in question should
decrease with increasing chain length if the stability of the
monomeric nucleus is the source of the increased rate of
aggregation with increasing chain length. In our calculations,A B
C D
FIGURE 9 Average number of hydrogen bonds per
acceptor oxygen atoms. This plot is similar to Fig. 5 except
that the hydrogen-bond statistics are shown for simulations
with two molecules. Only intermolecular hydrogen bonds
are shown. Q5 is excluded from this plot, since no intermo-
lecular hydrogen bonds are detected in these simulations.Biophysical Journal 97(1) 303–311
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(Fig. S2) as well as the spontaneities of intermolecular asso-
ciation show clear dependence on chain length. In a poor
solvent, longer chains form disordered globules of increased
stability. The more stable the globules, the more favorable
the dimers (12), and the harder it is to dissociate the dimers.
Although conformational restraints toward high fb values
lead to increases in solute-solvent interfaces and increased
b-content, these do not translate into increased spontaneity
for intermolecular associations. This observation points to
poorness of the solvent, as opposed to the associativities
ascribed to specific structures, as the invariant and generic
driving force for promoting aggregation of homopolymers.
Even though high b-content remains just as thermodynami-
cally unfavorable at the dimer level as at the monomer level,
the formation of intermolecular interfaces between restrained
chains promotes the formation of canonical backbone-driven
b-sheet structures. Other approaches to simulating polyglut-
amine conformational equilibria and aggregation have been
published (28,29). Clearly, comparative calculations using
different models are needed to test the model dependence
of our predictions and this is part of ongoing work.
Recent experiments (30) suggest that b-sheet formation is
a feature of large aggregates. It was also shown that large
nonspecific aggregates form before nucleated formation of
ordered fibrils. These observations are consistent with
extrapolations from our calculations, specifically the data
shown in Fig. 9. In Fig. 1, we summarize conceivable routes
from the ensemble of disordered globules to the high molec-
ular weight, ordered fibrillar aggregates. The homogeneous
nucleation model, with a monomeric nucleus, is highlighted
in gray. An alternative proposal, consistent with our results
and recent experimental data of Lee et al. (30), is follows:
Disordered globules reversibly associate to form a broad
distribution of disordered oligomers. These oligomers can
be described as being ‘‘molten’’ (31) or ‘‘liquid-like’’ (32)
and may be large enough to be referred to as ‘‘mesoglo-
bules’’ (33). Molten oligomers are peptide-rich microphases,
and chains in the interior are solvated by other chains. These
peptide-peptide interfaces should be more favorable than
peptide-solvent interfaces in a poor solvent. Peptides within
concentrated droplets can become indifferent to preferring
intramolecular interactions to intermolecular interactions
and consequently, individual chains can expand. In the
ensuing conformational sampling, a presumed slow step,
chains can converge on energetically favorable conforma-
tions that are high in b-content. Our proposal is similar to
those of others for polyglutamine (30), Ab (34), and the
N-domain Sup35 (31) but needs to be tested using appro-
priate simulations.
SUPPORTING MATERIAL
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